Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma

Proteomics

Volumn 15, Issue 19, 2015, Pages 3394-3404

  Wu, Chih Ching ^a,b   Chu, Hao Wei ^a   Hsu, Chia Wei ^b   Chang, Kai Ping ^b,c   Liu, Hao Ping ^d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Biomarker; Biomedicine; Oral cancer; Resistin; Salivary proteome

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; RESISTIN; SALIVA PROTEIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; METABOLISM; METASTASIS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SALIVA; SECONDARY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTEOME; SALIVA; TANDEM MASS SPECTROMETRY;

EID: 84942987797     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500157     Document Type: Article

References (31)

1. Siegel, R. L., Miller, K. D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 2015, 65, 5-29.
2. Cancer registration system annual report 2013. Department of Statistics, Ministry of Health and Welfare, Executive Yuan, Taiwan (http://www.mohw.gov.tw/EN/Ministry/Index.aspx).
3. Chen, Y. J., Chang, J. T., Liao, C. T., Wang, H. M. et al., Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008, 99, 1507-1514.
4. Liu, S. Y., Lu, C. L., Chiou, C. T., Yen, C. Y. et al., Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan. Oral Oncol. 2010, 46, 276-282.
5. Chang, K. P., Wu, C. C., Fang, K. H., Tsai, C. Y. et al., Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma. Oral Oncol. 2013, 49, 802-807.
6. Yu, C. J., Chang, K. P., Chang, Y. J., Hsu, C. W. et al., Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J. Proteome Res. 2011, 10, 3778-3788.
7. Chang, K. P., Chang, Y. T., Liao, C. T., Yen, T. C. et al., Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clin. Chim. Acta 2011, 412, 980-987.
8. Wu, C. C., Chang, Y. T., Chang, K. P., Liu, Y. L. et al., Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2014, 23, 1569-1578.
9. Yakob, M., Fuentes, L., Wang, M. B., Abemayor, E., Wong, D. T., Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances. Curr. Oral Health Rep. 2014, 1, 133-141.
10. Cuevas-Cordoba, B., Santiago-Garcia, J., Saliva: a fluid of study for OMICS. OMICS 2014, 18, 87-97.
11. Hu, S., Arellano, M., Boontheung, P., Wang, J. et al., Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer. Res. 2008, 14, 6246-6252.
12. Wang, Q., Yu, Q., Lin, Q., Duan, Y., Emerging salivary biomarkers by mass spectrometry. Clin. Chim. Acta 2015, 438, 214-221.
13. Bsoul, S. A., Huber, M. A., Terezhalmy, G. T., Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J. Contemp. Dent. Pract. 2005, 6, 1-16.
14. Chen, Y. J., Lin, S. C., Kao, T., Chang, C. S. et al., Genome-wide profiling of oral squamous cell carcinoma. J. Pathol. 2004, 204, 326-332.
15. Ho, P. S., Chen, P. L., Warnakulasuriya, S., Shieh, T. Y. et al., Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer 2009, 9, 260.
16. Wu, C. C., Peng, P. H., Chang, Y. T., Huang, Y. S. et al., Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics 2008, 8, 3605-3620.
17. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J. et al., Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 2010, 9, 1100-1117.
18. Chen, C. D., Wang, C. L., Yu, C. J., Chien, K. Y. et al., Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion. J. Proteome Res. 2014, 13, 2818-2829.
19. Hsu, C. W., Yu, J. S., Peng, P. H., Liu, S. C. et al., Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma. J. Proteome Res. 2014, 13, 4796-4807.
20. Liu, P. J., Chen, C. D., Wang, C. L., Wu, Y. C. et al., In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery. Mol. Cell. Proteomics 2015, 14, 917-932.
21. Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K. et al., STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015, 43, D447-D452.
22. Wang, H. J., Hsieh, Y. J., Cheng, W. C., Lin, C. P. et al., JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc. Natl. Acad. Sci. USA 2014, 111, 279-284.
23. Ghazali, N., Shaw, R. J., Rogers, S. N., Risk, J. M., Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review. Oral Oncol. 2012, 48, 1090-1100.
24. Li, Y. F., Sung, F. C., Tsai, M. H., Hua, C. H. et al., Interactions between cigarette smoking and polymorphisms of xenobiotic-metabolizing genes: the risk of oral leukoplakia. Dis. Markers 2013, 34, 247-255.
25. Peng, P. H., Wu, C. C., Liu, S. C., Chang, K. P. et al., Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J. Proteomics 2011, 74, 744-757.
26. Diakowska, D., Markocka-Maczka, K., Szelachowski, P., Grabowski, K., Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients. Dis. Markers 2014, 2014, 619649.
27. Ntikoudi, E., Kiagia, M., Boura, P., Syrigos, K. N., Hormones of adipose tissue and their biologic role in lung cancer. Cancer Treat. Rev. 2014, 40, 22-30.
28. Nieman, K. M., Romero, I. L., VanHouten, B., Lengyel, E., Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Acta 2013, 1831, 1533-1541.
29. Nakajima, T. E., Yamada, Y., Hamano, T., Furuta, K. et al., Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci. 2010, 101, 1286-1291.
30. Nakajima, T. E., Yamada, Y., Hamano, T., Furuta, K. et al., Adipocytokines and squamous cell carcinoma of the esophagus. J. Cancer Res. Clin. Oncol. 2010, 136, 261-266.
31. Nakajima, T. E., Yamada, Y., Hamano, T., Furuta, K. et al., Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J. Gastroenterol. 2009, 44, 685-690.